In today’s oncology, precision begins at the molecular level. Next-Generation Sequencing (NGS) doesn’t just decode your DNA; it unlocks a complete biological map that helps oncologists target cancer more accurately than ever before. At Neeli Genetics, NGS is integrated into a multi-omic platform that guides powerful immunotherapies like Clavi-Q-RE, bringing personalised, non-toxic, and highly targeted care within reach.
NGS provides deep insights across 4 biological layers of your tumour’s profile:
Together, these data layers fuel the RGCC Onconomics Plus, Oncotrace, and Immune Frame panels, turning test results into personalised action plans.
In 2025, cancer treatment starts not with a guess but with your genetic code. At Neeli Genetics, Next-Generation Sequencing is more than a test; it’s the foundation of personalised, immune-guided, and evidence-based care. You’re not just detecting cancer, and you’re outsmarting it.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
© 2025 Neeli Genetics. All Rights Reserved.